Company ProfilePremium

Bodal Chemicals Ltd.

Company Profile Analysis

Tickers: BODALCHEM.NS, 524370.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Bodal Chemicals Ltd. - Company showcase

Year Founded & Workforce

1986

1,625 Employees

Bodal Chemicals Ltd. logo

Bodal Chemicals Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Bodal Chemicals Ltd. Overview

Bodal Chemicals is an Ahmedabad-based, promoter-run chemical manufacturer that describes itself as India's largest integrated producer of dyestuffs and dye intermediates. Its model runs from sulphur-based basic chemicals through dye intermediates such as Vinyl Sulphone and H-Acid to finished reactive, acid and direct dyes, with roughly 40% of each upstream layer consumed captively. Since 2021 it has diversified through a chlor-alkali complex at Rajpura in Punjab, a TCCA water-treatment chemical business, and a greenfield benzene-derivatives site at Saykha in Gujarat. Consolidated revenue crossed Rs 2,000 crore in FY2026 for the first time since FY2022, and Q1 FY2027 delivered record quarterly revenue of about Rs 715 crore. The balance sheet remains the constraint: borrowings of Rs 813 crore, sub-investment-grade-adjacent ratings (IND BBB+ and IVR A-), return on equity near 4%, and no dividend since FY2023. The share price tripled in the year to October 2026.


What the company does. Bodal manufactures about 200 chemical products across five lines: basic (sulphur-based) chemicals, dye intermediates, dyestuffs, chlor-alkali products, and, more recently, benzene downstream derivatives and trichloroisocyanuric acid (TCCA). The Q1 FY2027 investor presentation gives total installed capacity of about 470,000 MTPA across eight manufacturing facilities in Gujarat, Punjab and Uttar Pradesh.

The company's own description. The FY2025-26 Annual Report presents the year as a pivotal chapter defined by strategic clarity, and identifies the commissioning of the Saykha greenfield facility as central to that progress. It describes Saykha as the company's entry into benzene derivatives (MCB, PNCB, ONCB, MNCB and DCB), opening pharmaceutical, agrochemical, pigment and polymer markets, and says the site uses German adiabatic nitration technology. The FY2024-25 Annual Report calls Bodal "India's largest integrated manufacturer of dyestuffs and dye intermediates".

Independent characterisation. Bodal is best understood as a mid-sized, vertically integrated commodity-to-semi-specialty chemical producer whose earnings are driven by spreads on a few benchmark molecules. Vinyl Sulphone and H-Acid prices set dye intermediate profitability. Caustic soda realisations (ECU) set chlor-alkali profitability. Sulphur prices pass through basic chemicals revenue. The "specialty" label applies to a minority of the portfolio (TCCA, some benzene derivatives, liquid dyes). The integration is real and lowers cost, but it does not insulate margins: consolidated operating margin fell from 16–18% in FY2015–FY2019 to 8–11% in FY2022–FY2026 (Screener.in, consolidated).

Revenue model. Revenue is almost entirely product sales, sold at spot or short-contract prices to industrial buyers and distributors. There is no subscription, licensing or service revenue of note. Minor other streams are trading by subsidiaries (India, China, Indonesia, Bangladesh), export incentives, and state incentive income (Rs 26.98 crore of Punjab SGST incentive recognised in FY2026).

Value chain position.

Customers and reach. Trade Brains (August 2026, citing company material) reports more than 600 customers served through 70+ distributors. The Q1 FY2027 presentation claims presence in 30+ countries. On a standalone basis exports were 21% of FY2026 sales, down from 25% in FY2025.

End-markets. Textiles dominate demand for dyestuffs and, indirectly, intermediates. Leather and paper are secondary. Chlor-alkali serves paper, textiles, soaps and alumina. Benzene derivatives and TCCA are the routes into pharmaceuticals, agrochemicals, pigments, polymers and water treatment.

Strategy

Stated themes (Annual Reports FY2025 and FY2026; results commentary). The company frames its strategy around integration, diversification beyond dyes, compliance-led manufacturing, and balance sheet repair. The FY2026 Annual Report title pairs "Excellence" with "Sustainability". Earlier (2022), Ankit Patel said the aim was to be among the top five Indian companies in benzene chemistry.

Medium-term financial guidance. Management guided FY2027 revenue of Rs 2,000–2,100 crore at a 12–13% EBITDA margin (Tijori Finance summary of the call). Q1 FY2027 revenue of Rs 715 crore annualises well above that range, while the 10.5% margin is below it. Either the revenue guidance is conservative or management expects raw-material-driven prices to ease. No guidance beyond FY2027 was found.

Sustainability commitments. The company cites zero liquid discharge at multiple sites, effluent treatment plants and multiple-effect evaporators, bluesign system partnership, and waste-heat power. Quantified emissions targets were not found.

Cost programmes. No named cost programme with a rupee target. The Vatva closure and working-capital reduction (net working capital days 124.9 to 104.8) are the tangible measures.

Products & Services

Product lists are from the Q3 FY2026 investor presentation (via Screener.in) and the company website. Pricing is market-linked and not disclosed for any product. Launch years are given only where disclosed.

Basic Chemicals (about 12 products; capacity 217,600 MTPA per Q1 FY2027 deck)

ProductDescription and useNotes
Sulphuric AcidMade from sulphur; feedstock for intermediates, fertilisers and detergentsCore of the integration chain
Oleum 23%Fuming sulphuric acid for sulphonationCaptive and merchant
Oleum 65%High-strength oleum for dye and pharma sulphonationCaptive and merchant
Sulphur TrioxideSulphonating agentLiquid SO3 also planned at Saykha
Chlorosulphonic AcidKey input for Vinyl SulphoneLargely captive
Thionyl ChlorideChlorinating agent for dyes, agro and pharma36,000 MTPA plant commissioned March 2019 at Unit VII
Sodium BisulphateBy-product saltMerchant
AcetanilideInput for Vinyl SulphoneBackward integration
Beta NaphtholNaphthalene derivative for dyes and pigmentsMerchant and captive
Para Nitro AnilineIntermediate for azo dyes and pigmentsMerchant and captive

Dye Intermediates (about 25 products; capacity 38,400 MTPA)

ProductDescription and useNotes
Vinyl Sulphone and derivativesReactive group for reactive dyes; Bodal's founding product6,000 MTPA line at the former SPS unit commercialised FY2023; price benchmark for the business
H-AcidCoupling component for reactive and acid black/blue dyes3,000 MTPA at Kosi; second price benchmark
DASADiamino stilbene disulphonic acid; optical brighteners and direct dyes—
F.C. AcidCoupling component—
Gamma AcidNaphthalene-based coupling component—
K-AcidUsed in reactive yellows—
Sulpho Tobias AcidUsed in reactive reds—
4-NADPSANitro amino diphenylamine sulphonic acid; acid dyes—
6-NitroDiazo component—
MPDSAMeta-phenylene diamine sulphonic acid—
Meta Ureido AnilineReactive yellow and orange dyes—
1:2:4 DiazoDiazo component for acid and chrome dyes—
BDSABenzidine disulphonic acid; used in Reactive Yellow 84, Reactive Orange 84, Acid Red 97, Acid Yellow 42Company website

Dyestuffs (about 175 products; about 35,000 MTPA powder plus 10,000 MTPA liquid per earlier decks)

Product familyDescription and target customerNotes
Reactive DyesCellulosic (cotton) dyeing; largest familySold to textile processors and distributors in India, Bangladesh, Turkey and others
Acid DyesWool, silk, nylon and leather—
Direct DyesPaper and cotton—
Liquid DyesPaper and textile continuous processes10,000 MTPA; utilisation above 50% by August 2020

Chlor Alkali (about 6 products; Rajpura, Punjab; 99,000 MTPA caustic soda)

ProductDescriptionNotes
Caustic Soda LyeMembrane-cell caustic82,500 MTPA at acquisition, upgraded to 99,000 MTPA in FY2023
Caustic Soda FlakesSolid caustic33,000 MTPA flaking capacity (company website)
ChlorineCo-productRegional sales
HydrogenCo-product—
Hydrochloric AcidChlorine derivative—
Sodium HypochloriteBleach and disinfectant—
Stable Bleaching PowderWater treatment—

Benzene Downstream (Saykha, Gujarat; 63,000 MTPA)

ProductDescriptionNotes
MCB (Monochlorobenzene)Chlorination of benzene; base for nitrochlorobenzenesCommissioned in phases from December 2023
PNCB (Para-nitrochlorobenzene)Pharma (paracetamol chain), dyes, agroAnnual Report FY2026 cites continuous crystallisation technology
ONCB (Ortho-nitrochlorobenzene)Pigment and agro intermediates—
MNCB (Meta-nitrochlorobenzene)Specialty intermediates—
DCB (Dichlorobenzenes)Polymers (PPS), agro—

Water Purification

ProductDescriptionNotes
TCCA 90Trichloroisocyanuric acid, >90% available chlorine, moisture 0.5% max12,000 MTPA at Khambhat; zero-effluent plant; US EPA registration no. 99758-1 (company website)
SDIC 60%Sodium dichloroisocyanurate2,400 MTPA shown as "upcoming" on the website

Financial Narrative

All figures consolidated, Rs crore unless stated, from Screener.in's transcription of audited statements. EBITDA is operating profit plus other income. Company-reported "total revenue" includes other income and is slightly higher (FY2026: Rs 2,053.9 crore).

Income statement

Gross profit. Bodal does not publish a gross profit line, and third-party aggregates are inconsistent with each other, so gross profit is treated as not publicly disclosed in a comparable form.

Revenue CAGR. FY2022–FY2026 (4 years): -0.5%. FY2021–FY2026 (5 years, base Rs 1,226 crore): 10.4%. The five-year figure flatters because FY2021 was a pandemic trough.

Source conflicts. TipRanks shows FY2022 net income of about Rs 104 crore against Screener's Rs 99 crore, likely a difference in treatment of minority interest. The company's FY2026 release gives EBITDA of Rs 202.85 crore and PAT of Rs 47.83 crore, matching the table. MarketsMojo's Q4 FY2026 note cites "annual net profit of Rs 18 crore"; that is the FY2025 figure.

Commentary. Revenue peaked in FY2022 on post-pandemic restocking, fell 32% over two years as intermediate prices collapsed, and recovered to Rs 2,012 crore in FY2026. Profit did not follow. FY2026 EBITDA was below FY2022 despite Rs 600 crore more gross fixed assets, because Saykha added depreciation and interest before it added margin. Interest cost nearly tripled, from Rs 29 crore to Rs 79 crore. FY2026 earnings also leaned on Rs 35 crore of other income and Rs 26.98 crore of Punjab SGST incentive booked in revenue (company results note). Stripping both out, pre-tax profit would have been close to zero.

Quarterly trend (consolidated, Rs crore; Screener.in)

Two quarters in the middle of FY2026 had operating margins under 5%, cushioned by other income. Q4 FY2026 and Q1 FY2027 show a different level of earnings: about Rs 30 crore of quarterly profit. Trailing-twelve-month revenue is Rs 2,267 crore and profit Rs 68.7 crore.

Balance sheet

Cash and equivalents, the short-term versus long-term debt split, and goodwill and intangibles could not be extracted from the audited statements and are not estimated. Net debt above is back-calculated from the company's published ratio and implies cash of roughly Rs 38 crore in both years. Rating letters give partial debt composition: India Ratings rated term loans of Rs 507.4 crore and working-capital limits of Rs 510 crore in July 2025.

Commentary. Borrowings rose from Rs 454 crore in FY2021 to Rs 911 crore in FY2025 to fund Rajpura and Saykha, then fell by Rs 98 crore in FY2026, the first meaningful reduction in six years. Equity grew only Rs 105 crore in four years.

Cash flow

No buyback was found in the period.

Commentary. FY2022–FY2024 absorbed about Rs 700 crore of capex. FY2026 is the inflection: investing cash flow turned positive (asset disposals exceeded spending), and Rs 191 crore went to debt service and repayment.

Ratios

ROIC and the current ratio are not computed because the cash and current-liability detail was not available. On FY2026 figures, net debt to EBITDA is about 3.8x (derived). MarketsMojo cites debt to EBITDA of 5.49x on its own multi-year averaging.

Commentary. Returns have been below any reasonable cost of capital for four years. The one clear operating improvement is working capital: the cash conversion cycle shortened by 60 days since FY2022, mainly through inventory.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityLocationStakeRole

Bodal Chemicals Ltd. (parent)

Gujarat, Punjab, Uttar Pradesh

—

All manufacturing

Bodal Chemicals Trading Pvt. Ltd. (BCTPL)

Gujarat, India

100%

Domestic trading; Q1 FY2027 sales Rs 6.52 crore

Bodal Chemicals Trading (Shijiazhuang) Co., Ltd.

China

100%

Trading; Q1 FY2027 sales Rs 1.09 crore (Rs 7.95 crore a year earlier)

Sen-er Boya Kimya Tekstil Sanayi ve Ticaret A.S.

Turkey

100%

Dyestuff manufacturing and distribution; hyperinflation accounting applies

Senpa Dis Ticaret A.S.

Turkey

100% (step-down)

Trading arm of Sen-er Boya

Bodal Bangla Ltd.

Bangladesh

100%

Market access to Bangladesh textile processors

PT Bodal Chemicals Indonesia

Indonesia

100%

Trading; Q1 FY2027 sales Rs 1.44 crore, loss-making

Plutoeco Enviro Association

Gujarat, India

25% (associate)

Not-for-profit environmental infrastructure company

Division Overview

DivisionFY2026

Dye Intermediates (INR Cr)

709.7

Dyestuffs (INR Cr)

529.4

Chlor Alkali (INR Cr)

338.7

Basic Chemicals (INR Cr)

165.5

Others incl. benzene downstream, TCCA, trading, other income (INR Cr, derived)

310.6

Total revenue (INR Cr)

2,053.9

Division Overview — Dye Intermediates

DivisionFY2026

Dye Intermediates (% of total)

34.6

Dyestuffs (% of total)

25.8

Chlor Alkali (% of total)

16.5

Basic Chemicals (% of total)

8.1

Others (% of total, derived)

15.1

Revenue by Segment

DivisionQ1 FY2026Q1 FY2027

Dye Intermediates (INR Cr)

150.4216.6

Dyestuffs (INR Cr)

121.1149.0

Basic Chemicals (INR Cr)

44.483.9

Chlor Alkali (INR Cr)

84.587.0

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

2,0551,5741,3951,7482,012

Operating expenses (INR Cr)

1,8351,4411,2841,5781,844

Operating profit before other income (INR Cr)

220133111171168

Other income (INR Cr)

-2129-135

EBITDA (INR Cr, derived)

218145120170203

Depreciation (INR Cr)

4753606970

Operating income / EBIT (INR Cr, derived)

1719260101133

Interest (INR Cr)

2941548279

Pre-tax income (INR Cr)

1425151954

Net income (INR Cr)

993861848

EPS basic and diluted (INR)

8.513.030.511.473.80

Dividend per share (Rs, derived from payout ratio)

0.800.10000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Operating margin before other income (%)

10.78.48.09.88.3

EBITDA margin (%)

10.69.28.69.710.1

EBIT margin (%)

8.35.84.35.86.6

Net margin (%)

4.82.40.41.02.4

Revenue growth YoY (%)

67.6-23.4-11.425.315.1

Income Statement and Margin Analysis (%)

MetricQ1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027

Sales (INR Cr)

454480490588709

Operating profit (INR Cr)

4823226969

Operating margin (%)

10.04.84.512.010.0

Other income (INR Cr)

4201536

Interest (INR Cr)

2220191819

Net profit (INR Cr)

10603230

EPS (INR)

0.760.480.022.552.41

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

2,1132,1202,2812,3392,336

Net fixed assets (INR Cr)

8179671,3141,3011,239

Capital work in progress (INR Cr)

70193686167

Other assets incl. working capital and cash (INR Cr)

1,2279608869771,031

Total borrowings (INR Cr)

676760904911813

Other liabilities (INR Cr)

385283294324366

Shareholders' equity (INR Cr)

1,0521,0781,0821,1051,157

Returns & Leverage Ratios and Working Capital (Days)

MetricFY2025FY2026

Net debt to equity (x, company presentation)

0.790.67

Net debt (INR Cr, derived from the ratio)

873775

Net working capital days (company presentation)

124.9104.8

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Cr)

-14290204114176

Investing cash flow (INR Cr)

-170-315-278-419

Financing cash flow (INR Cr)

1813381-73-191

Free cash flow (INR Cr, Screener definition)

-170-29-2969180

Net capex (INR Cr, derived as OCF minus FCF)

15631923345-4

Buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE (%, derived on average equity)

9.83.60.61.64.2

ROA (%, derived)

4.71.80.30.82.1

ROCE (%, Screener)

125366

Gross debt to equity (x, derived)

0.640.710.840.820.70

Gross debt to EBITDA (x, derived)

3.15.27.55.44.0

Interest coverage, EBIT / interest (x, derived)

5.92.21.11.21.7

Asset turnover (x, derived)

0.970.740.610.750.86

Debtor days

105971008380

Inventory days

141119139139106

Payable days

81721029781

Cash conversion cycle (days)

165144137125105

Revenue by Region (%)

RegionFY2025FY2026

Domestic (% of standalone sales)

7579

Export (% of standalone sales)

2521

Revenue by Region

RegionFY2025FY2026

Domestic (INR Cr, derived)

1,3001,590

Export (INR Cr, derived)

433423

Group Entities (Quarterly)

SubsidiaryQ1 FY2026 sales (INR Cr)Q1 FY2027 sales (INR Cr)Comment

Sen-er Boya (Turkey)

4.6 (derived from 41% growth)

6.48

PAT Rs 2.15 crore against a loss a year earlier

Bodal China (Shijiazhuang)

7.951.09

Sharp decline

PT Bodal Indonesia

—1.44

Loss-making

BCTPL (India trading)

2.466.52

Growth

“—” = not publicly disclosed.

Share Price & Returns

PeriodReturn

1 year

+202%

3 years

+33% a year compounded (about +135% cumulative, derived)

5 years

+8% a year compounded (about +47% cumulative, derived)

10 years

+2% a year compounded

52-week range

Rs 41.2 to Rs 208

Latest close

Rs 190 (1 October 2026)

Valuation Multiples

MultipleBodal (1 Oct 2026)Basis

P/E (TTM)

34.8

Screener.in

P/B

2.07

Rs 190 / book value Rs 91.9

EV / EBITDA (TTM)

About 13.9

Derived: EV about Rs 3,165 crore (market cap plus net debt about Rs 775 crore); TTM EBITDA about Rs 227 crore

EV / Sales (TTM)

About 1.4

Derived on TTM sales of Rs 2,267 crore

Dividend yield

0%—

Returns & Leverage Ratios (%) and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025FY2026

Dividend payout (% of profit)

2393000

Dividend per share (Rs, derived)

0.800.800.10000

Analyst Ratings & Targets

DateAgencyRatingAction
2023

India Ratings (Fitch group)

IND A / Negative; IND A1

Downgraded from IND A+ / IND A1+

29–30 Dec 2023

India Ratings

IND BBB+ / Negative; IND A2

Downgraded; term loan Rs 639 crore, working capital Rs 556 crore

8 Jul 2024

India Ratings

IND BBB+

—

17–22 Jul 2025

India Ratings

IND BBB+ / Stable; IND A2

Outlook revised to Stable; term loan Rs 507.4 crore

8 Dec 2025

Infomerics

IVR A- / Stable; IVR A2+

Assigned on Rs 1,127.53 crore, including proposed Rs 50 crore commercial paper

Analyst Conclusions

Management guidance. FY2027 revenue of Rs 2,000–2,100 crore at 12–13% EBITDA margin; Saykha towards 70–80% utilisation; TCCA volume growth of 10–15%; about Rs 120 crore of annual debt repayment; no major capex for two years.

Consensus. No usable consensus exists. Trailing revenue is already Rs 2,267 crore, above the top of guidance.

Bull case

  1. Earnings have reset. Two consecutive quarters of about Rs 30 crore profit imply Rs 120 crore annualised, 2.5 times FY2026.

  2. Operating leverage on sunk capital. Rs 700 crore of FY2022–FY2024 capex is now producing revenue with no further spend planned; each Rs 100 crore of debt repaid adds roughly Rs 9–10 crore to pre-tax profit at current borrowing costs (derived from FY2026 interest and debt).

  3. Protected and scarce positions. Sole Indian TCCA producer under a five-year duty; largest domestic intermediate producer as Indian compliance costs remove smaller rivals.

Bear case

  1. The price has run ahead. At 34.8 times trailing earnings and 2.1 times book for a business earning 4% on equity, the valuation assumes a recovery not yet delivered. A promoter-group member sold in late September.

  2. Margins are not improving. Q1 FY2027 EBITDA margin (10.5%) was below both the prior year and guidance. Revenue growth is largely price pass-through, which reverses when crude falls.

  3. Earnings quality and leverage. FY2026 profit relied on other income and an uncollected incentive; interest cover is 1.7 times; ratings are BBB+/A-.

Catalysts and monitorables (next 12 months)

ItemWhat to watch
Q2 FY2027 results (due November 2026)Whether quarterly PAT holds near Rs 30 crore and margin reaches 12%
SaykhaUtilisation level, pharma approvals, first disclosed divisional profit
DebtBorrowings below Rs 750 crore by March 2027
Punjab SGSTCash receipt of the Rs 26.98 crore accrual
Asset salesCompletion and proceeds for Unit I Vatva and Rajpura land
RatingsIndia Ratings review; any upgrade to the A category
ShareholdingFurther promoter-group sales; further accumulation by the 5% holder; any institutional entry
DividendResumption would signal balance sheet confidence
BoardSuccession for independent directors reaching ten years in 2027

Analyst verdict

Bodal Chemicals in October 2026 is two different stories depending on which quarter is read. On the five-year record it is a leveraged, low-return commodity chemical company that spent about Rs 700 crore diversifying at the top of a cycle, tripled its interest bill, and earned a cumulative Rs 209 crore over FY2022–FY2026 on more than Rs 1,000 crore of equity. On the last two quarters it is a recovering integrated producer with record revenue, falling debt, a finished capex programme and a tariff-protected niche.

Both readings are accurate. The operating recovery is real: volumes in dye intermediates rose 18% in Q1 FY2027, the working-capital cycle is 60 days shorter than in FY2022, and FY2026 produced Rs 180 crore of free cash flow. The investment case depends on whether Rs 30 crore of quarterly profit is a floor or a peak inflated by crude-linked pricing. The evidence does not yet settle that. EBITDA margin fell year on year in the record quarter, Saykha's benzene derivatives are still described by management as under competitive pressure, and FY2026 earnings needed incentive accruals and other income to look respectable.

The share price has not waited for the answer. A 202% gain, circuit-bound trading, no institutional holders and a promoter-group sale at the highs describe a stock driven by momentum more than by changed fundamentals. At Rs 190 the market capitalises Bodal at roughly 14 times trailing EBITDA, a multiple usually reserved for specialty chemical companies with mid-teens returns.

For a lender or counterparty, the direction is favourable: leverage is falling and the business is more diversified than at any time in its history. For an equity holder, the company must now deliver sustained 12–13% margins, visible Saykha profitability and continued debt reduction simply to justify the current price. The business is improving; the stock already assumes it has improved.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleOn board sinceAgeBackground

Suresh J. Patel

Chairman and Managing Director; promoter

31 May 2005 (MD from 13 May 2009)

70

Founder; started the business in 1989. Re-appointed for three years in 2025

Bhavin S. Patel

Executive Director; promoter group

31 May 2005 (whole-time from 1 Apr 2014 per MCA)

45

Son of the founder. Re-appointed for three years in 2025

Ankit S. Patel

Executive Director; promoter group

200843

Son of the founder; management's spokesperson on results; leads growth projects

Rajarshi Ghosh

Director – Health, Safety and Environment (executive)

26 May 2020

53

HSE professional

Nalin Kumar

Independent Director

13 Feb 2017

57—

Neha Sunil Huddar

Independent Director

9 May 2017

65—

Mayank Kulinchandra Mehta

Independent Director

9 Feb 2021

68—

Rohit B. Maloo

Independent Director

11 Dec 2022

——

Mayur B. Padhya

Chief Financial Officer (not on board)

——

Long-serving CFO; leads earnings calls

Ashutosh B. Bhatt

Company Secretary and Compliance Officer

——

Signs exchange filings

Bansibhai M. Patel

President – Production and Technical; promoter group

——

Holds 0.03%

“—” = not publicly disclosed.

Governance Overview

ItemPosition

Chair / CEO separation

Not separated; the founder is Chairman and Managing Director

Independence

4 of 8 directors (50%), the regulatory minimum for an executive-chair board

Family concentration

Three of four executive directors are father and two sons

Committees

Audit, Nomination and Remuneration, Stakeholders' Relationship, CSR, Risk Management (the last includes the CMD, an Executive Director, the HSE director, an independent director, the CFO and the President – Production)

Tenure watch

Two independent directors appointed in 2017 reach the ten-year limit in 2027

Pledges

Promoters declared no encumbrance on shares for FY2026 (filings of April and June 2026)

Board & Management Changes

DateChange

12 Aug 2025

Board recommends re-appointment of the CMD and one Executive Director for three years; recommends B N P S and Associates LLP as auditor

26 Sep 2025

Shareholders approve at the 39th AGM

25 Sep 2026

40th AGM; all resolutions passed

Major Shareholders

HolderCategoryStake (%)Source

Suresh J. Patel

Promoter

29.47

Exchange shareholding pattern

Bhavin S. Patel

Promoter group

8.33

Same

Ankit S. Patel

Promoter group

5.77

Same

Shakuntala J. Patel

Promoter group

5.29

Same

Ashokkumar Giriraj Bansal

Public, non-promoter

5.01

SAST disclosure; bought 1,75,000 shares on 11 Sep 2026 to reach 63,05,000

Meena S. Patel

Promoter group

4.15

Shareholding pattern

Ramesh D. Patel

Promoter group

About 3.8

Sold 1,70,000 shares on 29 Sep 2026; holding fell to 47,75,880

Rakesh R. Patel

Promoter group

0.04

Shareholding pattern

Bansi M. Patel

Promoter group

0.03

Shareholding pattern

Competitive Landscape

Competitors by Segment

LineNamed competitors

Dye intermediates (Vinyl Sulphone, H-Acid)

Kiri Industries, Bhageria Industries, Shree Pushkar Chemicals & Fertilisers, Kutch Chemical Industries (unlisted)

Dyestuffs

Kiri Industries, Atul Ltd., Jay Chemical Industries (unlisted), Colourtex (unlisted), Mahickra Chemicals; globally Zhejiang Longsheng, Zhejiang Runtu, Archroma, Huntsman-origin businesses

Pigment and colour peers (listed comparables)

Sudarshan Chemical Industries, Sudarshan Colorants India, Asahi Songwon Colors, Ultramarine & Pigments, Poddar Pigments, Vidhi Specialty Food Ingredients

Chlor-alkali

Primo Chemicals (formerly Punjab Alkalies), DCM Shriram, Gujarat Alkalies & Chemicals, Grasim Industries, Epigral

Benzene derivatives

Aarti Industries (dominant in nitrochlorobenzenes), Kutch Chemical, Panoli Intermediates, Seya Industries

Sulphuric acid and derivatives

Regional smelter and fertiliser acid producers; Aarti Industries

TCCA

Chinese and Japanese exporters (now under duty); Bodal is described by Reuters as India's sole producer

Peer Comparison FY2026

CompanyMarket cap (INR Cr)P/E (TTM)P/BROE (%)

Sudarshan Chemical Industries

8,831396.02.560.64

Kiri Industries

2,768

0.50 (distorted by a one-off gain)

0.4386.48

Ultramarine & Pigments

1,15114.251.329.28

Sudarshan Colorants India

92619.391.637.81

Bhageria Industries

91313.251.537.76

Bodal Chemicals (6 Aug 2026)

90013.110.784.13

Asahi Songwon Colors

44612.791.646.91

Poddar Pigments

26517.970.764.20

Mahickra Chemicals

25248.933.777.71

Bodal Chemicals (1 Oct 2026)

2,39034.82.07

About 4

Peer Comparison FY2026 — Revenue

MeasureBodal ChemicalsKiri IndustriesSudarshan ChemicalBhageria Industries

Revenue (INR Cr)

2,012 (FY2026)

About 950 (TTM, Value Research)

About 9,922 (TTM consolidated, Value Research)

—

Revenue growth

+15% (FY2026)

—

Not comparable (acquisition-driven)

—

Net margin

2.4% (FY2026)

Distorted by one-off gain

0.54%—

ROE

About 4%

86.5% (one-off)

0.64%7.76%

Integration

Sulphur to dyes; chlor-alkali; benzene

Intermediates to dyes

Pigments, global

Intermediates, solar

Recent Developments

--

Company Snapshot

$232.3M

Revenue

1,625

Employees

1986

Founded

Ahmedabad, India

Headquarters

SWOT Analysis

Strengths

  • Integration. About 40% of basic chemicals feed intermediates and about 40% of intermediates feed dyestuffs (Q1 FY2027 presentation).
  • Scale. About 470,000 MTPA across eight plants; the company describes itself as India's largest integrated dyestuff and intermediates maker.
  • Diversified base. Chlor-alkali contributed Rs 338.7 crore (16.5%) and Others Rs 310.6 crore (15.1%) of FY2026 revenue, neither of which existed in FY2020.
  • Working-capital discipline. Cash conversion cycle cut from 165 days (FY2022) to 105 days (FY2026).
  • Cash generation returning. Free cash flow of Rs 180 crore in FY2026 and borrowings down Rs 98 crore.
  • Policy protection. Five-year anti-dumping duty on TCCA from March 2025.
  • Unpledged promoter stake of 57%, confirmed for FY2026.

Weaknesses

  • Low returns. ROE 4.2% and ROCE 6% in FY2026; three-year average ROE 1.87% (Screener.in).
  • Leverage. Borrowings Rs 813 crore; gross debt to EBITDA 4.0x; EBIT covers interest 1.7 times.
  • Earnings quality. FY2026 pre-tax profit of Rs 54 crore included Rs 35 crore of other income and Rs 26.98 crore of accrued, uncollected state incentive.
  • Margin erosion. Operating margin 8.3% in FY2026 against 17% in FY2019.
  • No dividend for FY2024, FY2025 or FY2026.
  • Governance concentration. Combined Chairman and MD; three family members among four executive directors.
  • No institutional ownership. FII 0.02%, DII nil at June 2026.

Opportunities

  • Saykha utilisation. Management puts full utilisation at about Rs 300 crore of revenue.
  • TCCA growth. 10–15% volume growth guided on a 4,000 MT base, against 12,000 MTPA capacity.
  • Deleveraging. Rs 120 crore a year of repayments would cut interest (Rs 79 crore in FY2026) materially.
  • Asset sales. Unit I Vatva and Rajpura land, about Rs 25.5 crore book value.
  • Rating upgrade. India Ratings moved to Stable in July 2025; Infomerics already rates one notch higher.
  • Supply diversification away from China for pharma and agro intermediates, the stated rationale for Saykha.

Threats

  • Chinese pricing. Management cited intense competition in benzene derivatives through FY2026.
  • Input volatility. Q1 FY2027 EBITDA margin fell to 10.5% from 11.3% despite record revenue.
  • Incentive risk. The Rs 26.98 crore SGST receivable is subject to verification by Punjab authorities.
  • Environmental regulation. The Vatva closure shows legacy units can become unviable.
  • Currency and hyperinflation. Turkish subsidiary produced consolidated losses of Rs 1.0–1.3 crore per quarter.
  • Valuation and trading risk. Price up 202% in a year with repeated circuit locks; a promoter-group member sold on 29 September 2026.
  • Refinancing dependence on a small set of banks, at BBB+/A- ratings.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Mar 2025Five-year anti-dumping duty on TCCA from China and Japan; shares jump on 3x volumeProtects the Khambhat plant; Bodal described as sole Indian TCCA producer (Reuters)
May 2025FY2025 results: total revenue Rs 1,757 crore (+24%), EBITDA +43%, PAT Rs 18.5 croreRecovery year, but Saykha overheads dilute profit
May 2025CFO guides at least 4,000 MT of TCCA for FY2026First volume guidance after the duty
22 Jul 2025India Ratings revises outlook to Stable at IND BBB+; term loan rated amount cut to Rs 507.4 croreFirst positive rating action since 2022
Aug 2025Q1 FY2026: revenue about Rs 458 crore (+8%), EBITDA about Rs 52 crore (+40%), PAT Rs 9.5 croreMargin recovery to 11.3%
12 Aug 2025Board recommends re-appointment of CMD and an Executive Director; auditor change following firm mergerContinuity
2 Sep 2025Annual Report FY2024-25 filed—
26 Sep 202539th AGMResolutions approved
Sep 2025 quarterPromoter holding moves from 57.32% to 57.00%Small promoter-group sale
12 Nov 2025Q2 FY2026 results: sales Rs 480 crore, operating margin 4.8%, other income Rs 20 crore, PAT Rs 6 croreWeak operating quarter masked by other income
Nov 2025Consensus price target reported at Rs 107 (Simply Wall St)Thin coverage
8 Dec 2025Infomerics assigns IVR A-/Stable on Rs 957.53 crore and IVR A2+ on Rs 120 crore plus proposed Rs 50 crore commercial paperSecond agency, one notch above India Ratings
22 Jan 2026New charge registered (MCA)Refinancing or fresh facility
30 Jan 2026SEBI circular; company later opens special window for physical share transfers until 4 Feb 2027Administrative
14 Feb 2026Q3 FY2026: revenue from operations Rs 489.6 crore, EBITDA Rs 37.1 crore (-20%), PAT Rs 0.24 crore (-95.5%)Low point: Saykha overheads, new Labour Code provision, Rs 1 crore hyperinflation loss
Feb 2026Management says Saykha at normal production but margins under pressure from competitionSets expectations for a slow ramp
Mar 2026Share price near the 52-week low of Rs 41.2Trough
Mar–Apr 2026Company replies to BSE surveillance query on price movementStart of the rally
1 Apr 2026Trading window closed ahead of results—
4 Apr 2026Promoters declare no encumbrance for FY2026No pledges
21 May 2026FY2026: total revenue Rs 2,053.9 crore (+16.9%), EBITDA Rs 202.9 crore, PAT Rs 47.8 crore (+158%); Q4 PAT Rs 32.1 croreRevenue back above Rs 2,000 crore
21 May 2026Rs 26.98 crore Punjab SGST incentive recognised; sale of Unit I Vatva approvedEarnings quality caveat; asset monetisation
Jul 2026Stock up about 80% from March lows (Trade Brains)Re-rating under way
5 Aug 2026Q1 FY2027: revenue Rs 715.2 crore (+56%), EBITDA Rs 75.1 crore (+45%), PAT Rs 30.4 crore (+219%); margin 10.5%Record quarter; crude-linked input inflation passed through
6 Aug 2026Shares fall about 5% to Rs 71.5 the day after resultsMargin disappointment
31 Aug 2026Annual Report FY2025-26 and AGM notice filed—
11 Sep 2026Ashokkumar Giriraj Bansal crosses 5% (5.01%)New large non-promoter holder
15–18 Sep 2026Upper circuits on 15, 17 and 18 September; lower circuit on 16 SeptemberSpeculative, circuit-bound trading
21–22 Sep 2026All-time highs of Rs 199.95 then Rs 204.2Peak of the move
25 Sep 202640th AGM (virtual)Vatva closure and Saykha commissioning recorded
29 Sep 2026Promoter-group member Ramesh D. Patel sells 1,70,000 shares in the open market; trading window closesInsider selling into strength
1 Oct 2026Close Rs 190 (-4.3% on the day)Market cap Rs 2,390 crore

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

6 charts
Income Statement: Revenue & Gross Profit: Revenue from operations fell from INR 20,550 Mn in FY2022 to INR 20,120 Mn in FY2026.
Bodal Chemicals Ltd. — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from operations20,55015,74013,95017,48020,120

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.